
	Three Months Ended March 31,
(Dollars in thousands, except per share amounts)	2026		2025
Numerator
Net income (loss)	$	(9,054)	$	6,112

Denominator
Denominator for basic net income (loss) per share - weighted average outstanding shares of common stock	267,046,755		235,497,720
Dilutive effect of common stock options and SARs	—		2,490,510
Dilutive effect of RSUs	—		2,230,747
Dilutive effect of warrants	—		1,382,510
Dilutive effect of ESPP	—		1,366
Denominator for diluted net income (loss) per share - weighted average outstanding shares of common stock and assumed conversions	267,046,755		241,602,853
Basic net income (loss) per share	$	(0.03)	$	0.03
Diluted net income (loss) per share	$	(0.03)	$	0.03

Potentially dilutive securities including common stock options, RSUs, SARs and warrants have been excluded from the calculation of diluted net loss per share as their effects would be anti-dilutive. For the three months ended March 31, 2026 in which the Company reported a net loss, the weighted average number of shares outstanding used to calculate both basic and

diluted net loss per share were the same. The shares in the table below were excluded from the calculation of diluted net loss per share, prior to the use of the treasury stock method, due to their anti-dilutive effect:


			Three Months Ended March 31, 2026
Outstanding common stock options			21,236,218
SARs			635,313
Unvested RSUs			9,079,486

Warrants			2,115,385
Total			33,066,402